Recent Company News

• 07:17 AM ET Jul 07, 2026
  

  Alterity Therapeutics receives FDA End-of-Phase 2 meeting minutes confirming registrational pathway for ATH434 in multiple system atrophy (earlier, pre-AU open) (A$0.65, 0.00)

• 09:58 PM ET Jul 06, 2026
  

  StreetAccount Summary - Australia unusual volume traders

• 09:41 PM ET Jun 30, 2026
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 05:08 PM ET Jun 29, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:52 AM ET Jun 30, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 06:01 PM ET Jun 29, 2026
  

  StreetAccount Summary - After-hours trading update